{"component": "definition", "props": {"groups": [{"samples": [{"hash": "44WQ9qBWzJg", "uri": "https://ita.ac.tz/images/uploads/downloads/PROSPECTUS_2024-2025.pdf", "label": "ita.ac.tz", "score": 20.0876846313, "published": false}, {"hash": "bHeKxDqD5sf", "uri": "https://www.ita.ac.tz/images/uploads/downloads/ITA_PROSPECTUS_2024-2025.pdf", "label": "www.ita.ac.tz", "score": 19.8557682037, "published": false}, {"hash": "9jZQ2nOfOgm", "uri": "https://ita.ac.tz/images/uploads/downloads/ITA_PROSPECTUS_2022-2023_REVISED_PRINT_OF_MARCH29_FINAL.pdf", "label": "ita.ac.tz", "score": 11.6187543869, "published": false}], "snippet": "means a student\u2019s score below the minimum pass mark set by the Institute", "snippet_links": [{"key": "a-student", "type": "definition", "offset": [6, 15]}, {"key": "the-institute", "type": "definition", "offset": [59, 72]}], "size": 7, "hash": "0a8d447cc8e23606c515bf50723c5bf9", "id": 1}, {"samples": [{"hash": "5tFjHX77ImL", "uri": "http://www.chicagolemonlaw.com/ResponsetoMotiontoStrike.pdf", "label": "www.chicagolemonlaw.com", "score": 8.8165636063, "published": false}, {"hash": "fplcGivje1Y", "uri": "http://efile.illinoiscourts.gov/documents/SupremeCourt-eFileIL-Policy-User-Manual.pdf", "label": "efile.illinoiscourts.gov", "score": 8.1704311371, "published": false}, {"hash": "bmGRUUNYfvV", "uri": "https://courts.illinois.gov/EBusiness/Sup_Ct_Efiling/SCt_efiling_user_manual.pdf", "label": "courts.illinois.gov", "score": 7.845995903, "published": false}], "snippet": "means a malfunction of the EFM, EFSP, or the Court's hardware, software, and or telecommunications facility which results in the inability of a registered user to submit a document for e-filing. It does not include the failure of a user's equipment.", "snippet_links": [{"key": "the-court", "type": "clause", "offset": [41, 50]}, {"key": "telecommunications-facility", "type": "definition", "offset": [80, 107]}, {"key": "registered-user", "type": "clause", "offset": [144, 159]}, {"key": "to-submit", "type": "definition", "offset": [160, 169]}, {"key": "for-e", "type": "clause", "offset": [181, 186]}, {"key": "failure-of-a", "type": "clause", "offset": [219, 231]}], "size": 7, "hash": "8a6c0fe2102e700747b81a863732de83", "id": 2}, {"samples": [{"hash": "lgO6COH1YM", "uri": "https://www.flmd.uscourts.gov/sites/flmd/files/documents/flmd-administrative-procedures-for-electronic-filing-december-16-2021.pdf", "label": "www.flmd.uscourts.gov", "score": 14.7498722076, "published": false}, {"hash": "8kScXZq3a9S", "uri": "https://www.flmd.uscourts.gov/sites/flmd/files/documents/flmd-administrative-procedures-for-electronic-filing-12-1-2022.pdf", "label": "www.flmd.uscourts.gov", "score": 9.4544830322, "published": false}, {"hash": "ejVdKfhfIrV", "uri": "https://www.flmd.uscourts.gov/sites/flmd/files/documents/flmd-administrative-procedures-for-electronic-filing-11-7-2022.pdf", "label": "www.flmd.uscourts.gov", "score": 9.3887748718, "published": false}], "snippet": "means a malfunction of the Court\u2019s hardware, software, and/or telecommunications facility which results in the inability of a filer to submit a document electronically. Technical failure does not include the malfunctioning of a filer\u2019s equipment or internet connection.", "snippet_links": [{"key": "the-court", "type": "clause", "offset": [23, 32]}, {"key": "telecommunications-facility", "type": "definition", "offset": [62, 89]}, {"key": "to-submit", "type": "definition", "offset": [132, 141]}, {"key": "internet-connection", "type": "definition", "offset": [249, 268]}], "size": 6, "hash": "cbef42c1886efda913e80c331a1a41f3", "id": 3}, {"samples": [{"hash": "cNKwOWCz74F", "uri": "/contracts/cNKwOWCz74F#technical-failure", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 25.7227916718, "published": true}, {"hash": "eCIOWK5GFkW", "uri": "/contracts/eCIOWK5GFkW#technical-failure", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 25.6926765442, "published": true}, {"hash": "hWicZoQNPs", "uri": "/contracts/hWicZoQNPs#technical-failure", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 25.6570835114, "published": true}], "snippet": "means the discontinuation of Development or Commercialization of a Product for technical, scientific, medical or regulatory reasons, including, but, not limited to, unacceptable preclinical toxicity, demonstration of a side effect profile significantly worse than currently marketed products, or inability to manufacture in an acceptable purity or for an acceptable price.\n1. 104 \u201cTerm\u201d shall have the meaning assigned thereto in Section 14.1.", "snippet_links": [{"key": "discontinuation-of-development", "type": "clause", "offset": [10, 40]}, {"key": "not-limited", "type": "clause", "offset": [149, 160]}, {"key": "side-effect", "type": "definition", "offset": [219, 230]}, {"key": "marketed-products", "type": "definition", "offset": [274, 291]}, {"key": "inability-to-manufacture", "type": "clause", "offset": [296, 320]}, {"key": "acceptable-price", "type": "definition", "offset": [355, 371]}, {"key": "section-141", "type": "clause", "offset": [430, 442]}], "size": 6, "hash": "3cf3ca8558d1762ac9debf3c8b4c2d6f", "id": 4}, {"samples": [{"hash": "gPH4pUMuf3B", "uri": "https://imaging.occ.ok.gov/AP/CaseFiles/occ30459785.pdf", "label": "imaging.occ.ok.gov", "score": 11.0903491974, "published": false}, {"hash": "gjUkv9O19K8", "uri": "https://imaging.occ.ok.gov/AP/CaseFiles/occ30452536.pdf", "label": "imaging.occ.ok.gov", "score": 11.0506505966, "published": false}, {"hash": "8rgklqYyEgt", "uri": "https://oklahoma.gov/content/dam/ok/en/occ/documents/ajls/jls-courts/rules/2021/current-rules/chapter-5-rules-effective-2021-10-01.pdf", "label": "oklahoma.gov", "score": 10.8699522018, "published": false}], "snippet": "means a malfunction of Electronic Case Filing System hardware, software, and/or telecommunications facility which results in the inability of a registered Electronic Case Filing filer to file a document. It does not include the failure of a registered Electronic Case Filing filer's equipment, software, and/or telecommunications facility.", "snippet_links": [{"key": "system-hardware", "type": "definition", "offset": [46, 61]}, {"key": "telecommunications-facility", "type": "definition", "offset": [80, 107]}, {"key": "a-registered", "type": "clause", "offset": [142, 154]}, {"key": "to-file", "type": "definition", "offset": [184, 191]}, {"key": "failure-of-a", "type": "clause", "offset": [228, 240]}], "size": 6, "hash": "a08561ee88ef52b86c0e6014ee3ed241", "id": 5}, {"samples": [{"hash": "5ZLU0owkySn", "uri": "http://www.pamb.uscourts.gov/sites/default/files/general-ordes/MiscellaneousOrder_5-04-mp-50010-AmendedOrder-12-05-17.pdf", "label": "www.pamb.uscourts.gov", "score": 10.1704311371, "published": false}, {"hash": "dRFW4covq0Y", "uri": "http://www.pamb.uscourts.gov/sites/default/files/general-ordes/Local_rules_forms_Dec2018.pdf", "label": "www.pamb.uscourts.gov", "score": 9.424366951, "published": false}, {"hash": "jO7GtQ191z1", "uri": "http://www.pamb.uscourts.gov/sites/default/files/general-ordes/Local%20Rules%20Aug%201%202018.pdf", "label": "www.pamb.uscourts.gov", "score": 9.283367157, "published": false}], "snippet": "means any day on which the court\u2019s CM/ECF site is unable to accept filings continuously over a period of more than two (2) hours after 7:00 a.m.", "snippet_links": [{"key": "the-court", "type": "clause", "offset": [23, 32]}, {"key": "period-of", "type": "clause", "offset": [95, 104]}], "size": 5, "hash": "f61ca35202eef95795155bec26ce030f", "id": 6}, {"samples": [{"hash": "2yb2AZqCmQy", "uri": "https://www.sec.gov/Archives/edgar/data/1157602/000104746914007773/a2221442zex-10_10.htm", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 13.7227926254, "published": false}, {"hash": "9c11QZQfwIM", "uri": "https://www.sec.gov/Archives/edgar/data/1157602/000104746914007542/a2221384zex-10_10.htm", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 13.6926765442, "published": false}, {"hash": "jCQuS1naoxd", "uri": "https://www.sec.gov/Archives/edgar/data/1157602/000104746914007250/a2221275zex-10_10.htm", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 13.657084465, "published": false}], "snippet": "means the discontinuation of Development or Commercialization of a Product for technical, scientific, medical or regulatory reasons, including, but, not limited to, unacceptable preclinical toxicity, demonstration of a side effect profile significantly worse than currently marketed products, or inability to manufacture in an acceptable purity or for an acceptable price.", "snippet_links": [{"key": "discontinuation-of-development", "type": "clause", "offset": [10, 40]}, {"key": "not-limited", "type": "clause", "offset": [149, 160]}, {"key": "side-effect", "type": "definition", "offset": [219, 230]}, {"key": "marketed-products", "type": "definition", "offset": [274, 291]}, {"key": "inability-to-manufacture", "type": "clause", "offset": [296, 320]}, {"key": "acceptable-price", "type": "definition", "offset": [355, 371]}], "size": 5, "hash": "f9fb20706419ff32bd8c3e4fc6b7199c", "id": 7}, {"samples": [{"hash": "dlvIETDjVmb", "uri": "/contracts/dlvIETDjVmb#technical-failure", "label": "Option Agreement (Sorrento Therapeutics, Inc.)", "score": 24.5263519287, "published": true}, {"hash": "aplAGrmaFcf", "uri": "http://investors.sorrentotherapeutics.com/static-files/5d08792c-086e-414e-89c5-9bc79f642252", "label": "Amendment", "score": 14.1704311371, "published": false}, {"hash": "e3kuIoPQlsa", "uri": "http://investors.sorrentotherapeutics.com/node/7636/html", "label": "Amendment", "score": 14.1704311371, "published": false}], "snippet": "means STI\u2019s good faith determination [***].", "snippet_links": [{"key": "good-faith-determination", "type": "clause", "offset": [12, 36]}], "size": 5, "hash": "8978ac510a7286722fd3919415bea05d", "id": 8}, {"samples": [{"hash": "5QQ8kSgUDvm", "uri": "/contracts/5QQ8kSgUDvm#technical-failure", "label": "Strategic Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc)", "score": 30.1608486176, "published": true}, {"hash": "7yICmZPouEt", "uri": "/contracts/7yICmZPouEt#technical-failure", "label": "Strategic Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc)", "score": 29.1587944031, "published": true}, {"hash": "hkdYULuTDOl", "uri": "/contracts/hkdYULuTDOl#technical-failure", "label": "Strategic Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Isis Pharmaceuticals Inc)", "score": 24.8439426422, "published": true}], "snippet": "has the meaning set forth in Section 1.10.1(b).", "snippet_links": [], "size": 5, "hash": "5c9fc0ea9099b6674d34fe2183674834", "id": 9}, {"samples": [{"hash": "aeeFDr6sD3n", "uri": "/contracts/aeeFDr6sD3n#technical-failure", "label": "Mrna Cancer Vaccine Collaboration and License Agreement (Moderna, Inc.)", "score": 29.8542098999, "published": true}, {"hash": "h8TvRT5YTfq", "uri": "/contracts/h8TvRT5YTfq#technical-failure", "label": "Mrna Cancer Vaccine Collaboration and License Agreement (Moderna, Inc.)", "score": 29.659822464, "published": true}, {"hash": "g6a2xi8JHhf", "uri": "/contracts/g6a2xi8JHhf#technical-failure", "label": "Mrna Cancer Vaccine Collaboration and License Agreement", "score": 26.226556778, "published": true}], "snippet": "means with respect to a given Joint SAV Program, [***].", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [6, 21]}], "size": 4, "hash": "764d330ac93f0dc4a7c2b86527f39a2b", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIadGVjaG5pY2FsLWZhaWx1cmUjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "means a student\u2019s score below the minimum pass mark set by the Institute", "size": 184, "title": "Technical Failure", "id": "technical-failure", "examples": ["Any such failure, or any failure confirmed pursuant to Section 5.4, shall be deemed a \u201c<strong>Technical Failure</strong>\u201d and the provisions of Section 5.3 shall apply to such <strong>Technical Failure</strong>.", "For a given SAV Program, the Parties may suspend the conduct of activities under such SAV Program upon mutual written agreement that there is a <strong>Technical Failure</strong> with respect to the SAVs for such SAV Program, subject to the consequences in Section 3.2(b).", "Notwithstanding any such <strong>Technical Failure</strong>, during the Exclusivity Period with respect to such Option Target (a) Novartis may, in its sole discretion, purchase the Option for such Option Target by issuing an Option Purchase Notice in accordance with Section 4.1 of this Agreement, or (b) if Novartis has already delivered an Option Purchase Notice with respect to such Option Target, exercise its Option with respect to such Option Target by issuing an Option Exercise Notice.", "Dermavant shall not, and shall ensure that no Responsible Party shall, suspend or terminate the Program during the Term for any reason (including a commercially reasonable reason), except that Dermavant may: (y) terminate the Program for <strong>Technical Failure</strong> only in accordance with this Section 3.2 (Program Termination) or (z) effect a Non-Technical Termination only in accordance with this Section 3.2 (Program Termination).", "In the event of termination of development of a particular Alliance Product for <strong>Technical Failure</strong> and an alternative Alliance Product in the same Discovery Program replaces such Terminated Alliance Product then milestone payments for such alternative Alliance Product shall not be paid in respect of milestones already achieved by the Terminated Alliance Product.", "Dermavant shall not delay delivery of a Termination Notice so as to reduce the amount of any <strong>Technical Failure</strong> Termination Payment payable pursuant to Section 3.2(c)(ii) (Effect of Program Termination).", "In the event Dermavant reasonably and in good faith believes a <strong>Technical Failure</strong> has occurred, it shall provide to NovaQuest [***] notice of the same setting forth the details and evidence of the purported <strong>Technical Failure</strong> (\u201c<strong>Technical Failure</strong> Notice\u201d).", "Company shall have the right to terminate this Agreement in the event of a <strong>Technical Failure</strong>.", "If the Company does not terminate this Agreement in accordance with Sections 5.3.1 or 5.3.2 within the above ***** day time period (as may be extended pursuant to Section 5.2), this Agreement shall continue in spite of the relevant <strong>Technical Failure</strong> and Affimed shall use commercially reasonable efforts to continue to conduct activities under the Development Plan for the next Phase, and the Company shall pay *****, notwithstanding such <strong>Technical Failure</strong>.", "Parties (including, at a minimum, each Party\u2019s Senior Officer and Primary Contact) will meet in person to review and discuss the purported <strong>Technical Failure</strong> and the possible termination of the Program, and Dermavant will reasonably consider NovaQuest\u2019s feedback with respect to the <strong>Technical Failure</strong>."], "related": [["supply-failure", "Supply Failure", "Supply Failure"], ["epidemic-failure", "Epidemic Failure", "Epidemic Failure"], ["service-level-failure", "Service Level Failure", "Service Level Failure"], ["persistent-failure", "Persistent Failure", "Persistent Failure"], ["mi-failure", "MI Failure", "MI Failure"]], "related_snippets": [], "updated": "2026-03-21T04:22:45+00:00"}, "json": true, "cursor": ""}}